1. Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720–1748
2. Van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z (2010) Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol 8:486–498
3. Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, Raphael M (2002) Castleman’s disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 69:119–126
4. Payer E, Miltenyi Z, Simon Z, Magyari F, Barna S, Mehes G, Illes A (2012) Diagnostic and therapeutic difficulties in diffuse large B-cell lymphoma arising from HHV8 positive Castleman disease. J Hematol 1:65–69
5. Phulware RH, Ramteke P, Yadav R, Iyer VK, Mallick S (2022) Cytology of Castleman’s disease (hyaline-vascular type) masquerading as Hodgkin’s lymphoma. Am J Blood Res 12:196–200